Page last updated: 2024-12-07

ici 153066

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

ICI 153066: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID131280
SCHEMBL ID9660993
MeSH IDM0119429

Synonyms (10)

Synonym
ici-153,066
1h-1,2,4-triazole-1-ethanol, alpha-(2,4-dichlorophenyl)-alpha-(4-fluorophenyl)-
ici-153066
ici 153066
76674-22-1
1-(2,4-dichlorophenyl)-1-(4-fluorophenyl)-2-(1,2,4-triazol-1-yl)ethanol
SCHEMBL9660993
1-(2,4-dichlorophenyl)-1-(4-fluorophenyl)-2-(1,2,4-triazol-1-ylethanol
1-(2,4-dichlorophenyl)-1-(4-fluorophenyl)-2-(1h-1,2,4-triazol-1-yl)ethan-1-ol
DTXSID50997991

Research Excerpts

Compound-Compound Interactions

ExcerptReferenceRelevance
" Flucytosine combined with amphotericin B produced little or no reduction of the MICs at which 90% of the strains were inhibited compared with amphotericin B alone."( In vitro activities of amphotericin B in combination with four antifungal agents and rifampin against Aspergillus spp.
Gerding, DN; Harris, C; Hughes, CE; Moody, JA; Peterson, LR, 1984
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (19)

TimeframeStudies, This Drug (%)All Drugs %
pre-199016 (84.21)18.7374
1990's3 (15.79)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.30

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.30 (24.57)
Research Supply Index3.00 (2.92)
Research Growth Index4.29 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.30)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]